Stimulation of polymorphonuclear neutrophils (PMN) by phorbol esters or formyl peptides (fMLP) generates large quantities of superoxide anion, the so-called respiratory burst (RB). a phenomenon associated with intense phosphorylation of a 47-kD protein (p47 phox). Staurosporine, a potent protein kinase C (PKC) antagonist, inhibits both responses when PMN are stimulated by phorbol myristate acetate (PMA), suggesting a positive role of PKC. In this study, we reassessed these PMN responses in fMLP-stimulated cells and found that staurosporine had opposite effects depending on the duration of PMN treatment with staurosporine. Short PMN incubation (0.5 to 3 minutes) with 25 to 100 nmol/L staurosporine inhibited the fMLPinduced RB. whereas longer treatment (1 5 to 20 minutes) enhanced it by up to about 200% relative to controls. In contrast, the PMA-mediated RB was depressed by staurosporine in a time-dependent manner. A primed fMLP-induced RB was also observed after long (1 5 minutes) PMN treatment with 5 to 100 pmol/L H-7, whereas shorter treatment (5 minutes) resulted in a small decrease in RB. By contrast, the tyrosine kinase inhibitor genistein (2 to 80 pmol/L) depressed fMLP-induced RB whatever the dura-TIMULATION of polymorphonuclear leukocytes S (PMN) and other phagocytes (monocytes and macrophages) results in rapid production of superoxide, the socalled respiratory burst (RB), which plays a key role in the killing of bacteria.',2 The superoxide-generating NADPH oxidase system, which is dormant in resting phagocytes, is activated on phagocyte exposure to a variety of stimuli such as chemoattractants (fMLP, leukotriene B4, and complement fraction C5a), phorbol esters (eg, phorbol myristate acetate [PMA]), or particle^.^ Nonstimulatory concentrations of agonists accelerate and potentiate the RB induced by a second stim~lus.~,' This priming is thought to occur through a mechanism different from that involved in the stimulatory process.6 The NADPH oxidase system comprises both membrane and soluble components, including two cytosolic proteins with molecular masses of 47 and 67 kD.7-9 The absence of these proteins in some types of granulomatous diseasei0'l2 results in failure of PMN to generate superoxide. The biochemical mechanism responsible for superoxide production in PMN has been extensively stud-
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tion of PMN treatment. Analysis of 32P-phosphorylated proteins in fMLP-stimulated cells showed that short PMN treatment ( < 8 minutes) with staurosporine abolished the phosphorylation of the 47-kD protein, which was identified as p47 phox, whereas long treatment partially restored p47 phox phosphorylation up to approximately 50% of the control value. In PMA-stimulated PMN, phosphorylation was reduced in a time-dependent manner. Furthermore, the staurosporine-primed RB and the staurosporine-induced recovery of phosphorylation were inhibited by sphingosine but not by genistein. Thus, in addition to its known depressive effect, staurosporine markedly potentiated fMLP-stimulated RB as a function of the duration of PMN treatment. The restoration of p47 phox phosphorylation suggests that staurosporine may alter the interactions between different protein kinases, producing marked timedependent changes in signalling pathways. These data emphasize the care that should be taken in interpreting data obtained using this kinase inhibitor that may, however, be helpful analyzing in signalling pathways. ied and is believed to involve both protein kinase C (PKC)-dependent and -independent pathways.I3-l6 PKC inhibitors have been used to analyze the role of PKC in signal transduction and cell functions. Phorbol-ester stimulation of the RB and phosphorylation ofthe 47-kD protein are depressed by PKC antagonists such as H-7'5.'7,'8 and staur~sporine,''~'~ pointing out a positive role of PKC in these responses. By contrast, reported alterations of chemoattractant-mediated RB by staurosporine have been variable; a number of investigators have described depressed RB,'5,'8,'9 and others have found it unchanged" or enh a n~e d , " -~~ suggesting different roles of PKC2'
To gain insight into the role of PKC in chemoattractantmediated PMN stimulation, we reassessed RB and protein phosphorylation in staurosporine-treated human PMN and show that the duration treatment with staurosporine is a crucial parameter that conditions either inhibition or priming of the RB by fh4LP-stimulated PMN.
MATERIALS AND METHODS

Reagents.
Staurosporine was from Kamiya Biochemical (Thousands Oaks, CA). HC1-free ['*PI phosphoric acid (specific activity, 320 TBq/mmol) was from New England Nuclear (Boston, MA). Hionic Fluor was from Packard, BV (Breda, the Netherlands). Genistein was from L.C. Services Corp (Woburn, MA). The monoclonal antibody (MoAb) against p47 phox was kindly provided by Dr B.M. Babior (Scripps Research Institute, La Jolla, CA). The MoAb against granule membrane protein (GMP 140) was from Becton Dickinson (San Jose, CA). Other reagents were from Sigma (St Louis, MO). Sphingosine was dissolved in dimethyl sulphoxide and diluted in an equimolar aqueous solution offatty acidfree bovine serum albumin (BSA).
Heparinized human venous blood from healthy volunteers was centrifuged over a cushion of a mixture of Ficoll and Hypaque (Monopoly resolving medium; Flow Laborato- ries, Puteaux, France) as described previously?' The purified PMN were subjected to hypotonic lysis, washed, and resuspended in Hanks' Balanced Salt Solution (HBSS) with 1.2 mmol/L CaCI,.
Isolation of PMN.
PMN RB. The production of superoxide anion was continuously recorded by monitoring the superoxide dismutase-inhibitable reduction of cytochrome C,2',24 using a UVIKON 860 spectrophotometer (KONTRON Instruments, Zurich, Switzerland) equipped with a thermostated (37°C) cuvette holder and a magnetic stirrer.
Suspensions of 2 x lo6 PMN in 2 mL HBSS were incubated in the absence (control) or presence of kinase inhibitors for various times before stimulation. The final concentration of drug solvent did not exceed 0.1% and had no discernable effect on RB. Results are expressed in nanomoles of superoxide per minute and per IO6 PMN, calculated in initial rate conditions, ie, from the linear part of the curve. The viability of PMN, which had been treated with the drugs and stimulated, was checked using the Trypan-blue exclusion method. Except for sphingosine, which was associated with approximately 20% of dead cells (versus 7% to 8% in controls), the drugs were not cytotoxic. . Postnuclear supernatants were centrifuged at lO0,OOOg for 60 minutes in a Beckman TLlOO (Beckman Instruments, Palo Alto, CA) and the soluble fraction was separated from the pellets (paniculate fractions). Protein was assayed with BIO-RAD assay (Ivry-sur-Seine, France) and precipitated with an equal volume of 20% trichloracetic acid. Precipitates were washed twice with water, solubilized with electrophoresis buffer comprising 10 mmol/L Tris, 10% sucrose, 1 mmol/L EDTA, 0.5 mol/L mercaptoethanol and 2.5% sodium dodecyl sulfate (SDS), boiled for 3 minutes, and neutralized with 0.1 mol/L NaOH. Samples (25 pg) were electrophoresed on a polyacrylamide gel containing 0.05% SDS.26 The gels were stained, fixed, and autoradiographed with intensifying screens with Kodak X-OMAT films (Eastman-Kodak, Rochester, NY). Phosphorylated proteins were predominantly present in the soluble fraction. It is possible that some particle-bound protein was released during the sonication step, and the results are thus those obtained with the soluble fractions.
Identification of p47 phox. Protein A sepharose was prepared by swelling the beads in distilled water for 30 minutes. The beads were sedimented and resuspended in lysis buffer containing 5% BSA, 0.01% sodium azide, and a soluble fraction of unlabeled PMN (I%), and rocked for 1 hour at 4°C.26 They were then washed 3 times with distilled water and resuspended in an equal volume of water. Immunoprecipitation of p47 phox was performed by incubating soluble fraction of IO' [32P]-labeled PMN with 25 pg of MoAb" for 2 hours at 4°C and then with 100 pL of protein A-sepharose beads for 2 hours at 4°C. The immune complex was sedimented by centrifugation (l0,OOOg for 3 minutes), washed 3 times with 0.5 mL of lysis buffer, and washed twice with 0.5 mL of 10 mmol/L Tris, pH 7.4. Finally, the pellet was resuspended in 100 pL of electrophoresis buffer, boiled for 3 minutes, and electrophoresed as described above. Autoradiography films were scanned using a densitometer (Onescanner; Apple Computer, Paris, France) with version 3.05 Image 1.45 gel analysis software.
Statistical analysis. Values are given as means f SEM of at least three duplicate experiments. Statistically significant differences between experiments were identified using Student's paired t-test.
RESULTS
Effect of the duration of PMN treatment with staurosporine onfMLP-and PMA-inducedRB. The effect of staurosporine on superoxide anion production by PMN stimulated with 100 nmol/L fMLP was analyzed as a function of the time of treatment (Fig 1, left panel) . Short treatment (0.5, 1, and 3 minutes) with staurosporine concentrations from 25 to 100 nmol/L inhibited the fMLP-induced RB, proportionally to the concentration of staurosporine. Surprisingly, when treatment with staurosporine was increased to 10 minutes, the inhibition was progressively lost, and longer treatments (1 5 and 20 minutes) enhanced the fh4LP-induced RB. The maximal effect was observed with PMN treated with 50 nmol/L of staurosporine for 20 minutes (213% f 12% of control values; P < .05). Staurosporine concentrations of 25 or 100 nmol/L were less effective (178 k 6; P < .05 and 18 1 k 15; P < .05). When PMN treatment exceeded 20 minutes, the enhancing effect was progressively lost, and no effect was detectable after 1 hour of treatment (data not shown). Staurosporine concentrations from 25 to 100 nmol/L induced a concentration-dependent inhibition of the PMA-mediated RB, as previously r e p~r t e d . '~, ' * ,~~ Maximal inhibition was reached after 30 seconds of PMN treatment with 100 nmol/L staurosporine and did not change with longer treatment (Fig 1, right panel) , a finding consistent with a positive influence of PKC in this model. H-7 and genistein onfMLP-and PMA-induced RB. The above results show that staurosporine primed the NLP-induced RB when the duration of cell treatment by staurosporine exceeded 10 minutes. To determine whether such a priming effect was unique to staurosporine, we analyzed the effect of two other kinase antagonists: H-7,28 an isoquinoline sulfonamide that interferes with the adenosine triphosphate-binding sites of PKC; and genistein, an isoflavine that inhibits tyrosine kinases.29 PMN were pretreated for short (3 minutes) and long (1 5 minutes) periods before stimulation with fMLP. Concentrations of H-7 ranging from 5 to 100 pmol/ L significantly enhanced the fMLP-induced RB ( P < .05) when the PMN treatment lasted 15 minutes (Fig 2, after treatment with H-7 for I5 minutes (Fig 2, right panel) , the RB was depressed in a concentration-dependent manner with an IC50 of approximately 100 pmol/L, in agreement with other report^.^@^'
Effect of the duration of PMN treatment with
Pretreatment of PMN for 3 and 15 minutes with 1 to 80 pmol/L genistein resulted in a concentration-dependent inhibition of the fMLP-induced RB, with an IC50 of approximately 10 pmol/L (Fig 2, middle panel) . These drug concentrations did not alter the PMA-mediated RB (Fig 2, right  panel) . in agreement with other data.33 However, a higher concentration of genistein of 200 pmol/L reduced the RB by only 20%.
The production of superoxide anion by a cell-free system consisting of a particulate fraction from PMA-stimulated PMN was not altered by staurosporine concentrations from 25 to 1,000 nmol/L (results not shown). The result indicates that staurosporine does not affect the catalytic activity of reconstituted NADPH oxidase. The above differential effects of staurosporine probably occur through alterations in signal transduction pathways.
Staurosporine both inhibited and potentiated the fMLPinduced RB when cells were pretreated for short (3 minutes) and long (15 minutes) periods, respectively. A possible mechanism for the enhanced staurosporine effect is that inhibition of PKC is reversed after 15 minutes. If this were the case, further short PMN treatment with kinase antagonists should reduce the priming effects of staurosporine. Al- ternatively, different kinases may be involved. To gain insight into these points, we set up a model in which PMN were first treated with staurosporine in priming conditions (1 5 minutes) and then in inhibiting conditions (3 minutes) with freshly added kinase inhibitors such as sphingosine, staurosporine, and genistein before stimulation with fMLP. Figure 3 compares the effects of the three drugs on both primed and unprimed fMLP-induced RB. When PMN were not treated by staurosporine, genistein (Fig 3, left  panel) depressed the fMLP-induced RB in a concentrationdependent manner, with a complete inhibition at 80 pmol/ L. Genistein also significantly reduced the total primed RB. However, the difference between the primed and unprimed productions, which may represent the response mediated by staurosporine, was not decreased by genistein. In contrast, sphingosine and staurosporine reduced (P < .05) the difference between the primed and unprimed RB, suggesting a possible regulation by PKC of the enhancing effect of staurosporine (Fig 3, middle and right panels) .
Staurosporine modulates the phosphorylation of the 47-kD protein in fMLP-stimulated PMN. In the generally accepted model for RB stimulation, PKC-dependent phosphorylation of proteins is required for the RB.',I6 Among these, a protein of 47 kD has been
The influence of the duration of treatment with staurosporine on protein phosphorylation in fMLP-stimulated 32P-labeled PMN is reported in Fig 4. . Among these, the phosphorylation of the 67 kD (p67) was depressed by short treatment and then restored for longer treatment as for the p47, suggesting its possible role in RB. However, the identity of this protein remains to be compared with that of the p67 phox. which is involved in oxidase activation. In PMAstimulated PMN. the phosphorylation of the p47 was decreased in a time-dependent manner by staurosporine ( Fig  5, lanes 6 through 10) . Increasing the time of PMN treatment with 50 nmol/L staurosporine did not markedly modify the phosphorylation pattern in unstimulated PMN ( When PMN pretreated with staurosporine for 20 minutes were again submitted to short treatment (3 minutes). ie, inhibiting conditions (Fig 6. lane 2) . with freshly added kinase antagonists (sphingosine, staurosporine, and genistein). only staurosporinc (50 nmol/L) and sphingosine ( I pmol/L) inhibited the restoration of the p47 phosphorylation mediated by long staurosporine treatment of PMN (Fig  6. lanes 6 and 7) . whereas genistein (50 pmol/L) had no effect (Fig 6, lane 5) .
IModrrlution o f t lie plir~.~plior~~iutiori ~f p 4 7 p1io.v by sturrrosporinc. To determine whether altered phosphorylation of p47 was due to the NADPH oxidase factor p47 phox. phox phosphorylation induced by fMLP was inhibited, whereas phosphorylation was partially restored after longer cell treatments (Fig 8, upper panel) . On the basis ofdensitometric analysis, the inhibition of phosphorylation was almost complete, whereas the restoration reached approximately 50'70 of the control value (Fig 8. lower panel) .
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DISCUSSION
The novel observation described in this study is that fMLP stimulation of the PMN RB is respectively prevented fecting early events triggered by chemoattractant receptor stimulation. That a potent, primed RB was also mediated by H-7 appears to be in contradiction with other data obtained with the same c o n c e n t r a t i~n~~~~~; however, it has been observed with rabbit PMN." The reasons for these discrepancies are unclear. but they may be partly due to differences in cell treatment. ie, the use of cytochalasin B,32 stimulant concentrations, and experimental conditions." Unlike H-7 and staurosporine. more selective PKC inhibitors such as G F 109203X4' and ~helerythrine~~ failed to prime fMLP-induced RB in our experimental conditions (results not shown). From these data. it is tempting to postulate that staurosporine may primarily alter early signaling events in a manner not related to PKC. The NADPH oxidase system responsible for generating superoxide, consists of both cytoplasmic and membrane components and is disassembled in unstimulated cell^."^ On stimulation, some cytoplasmic components translocate One possible explanation for these different effects may be related to the duration of cell treatment with staurosporine, as described here (Fig I) . We have reported that staurosporine also primes the platelet-activating factor (PAF)-induced RB." In unpublished studies. we found a similar enhancing effect of staurosporine on leukotriene B4 (LTB4)-induced and complement fraction C5a-induced but not ionomycine-induced PMN RB. Unlike PMA and ionomycine. fMLP, PAF. LTB4, and C5a bind to membrane receptors and stimulate PMN through a mechanism involving G protein-dependent activation of phospholipases. 40 These data raise the possibility that staurosporine priming of the RB may be due to metabolic alterations af- 
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to the plasma membrane, a phenomenon that has been implicated in the activation of the o x i d a~e .~~.~~ Phosphorylation of p47 phox by PKC44 plays a key role in this activat i~n .~~ Short PMN treatment with staurosporine drastically inhibited both superoxide production and phosphorylation of the p47 induced by fh4LP and PMA (Figs 4 and 5) , in keeping with earlier report^.'^,^' Interestingly, the fMLPbut not the PMA-induced RB was also prevented by short and long treatment of PMN with genistein (Fig 6) , which indicates that genistein may not alter PKC activation in these conditions. The results are consistent with the assumption that tyrosine kinase activation plays an important role in the signalling induced by fMLP. [45] [46] [47] Unlike short incubation, long treatment (1 5 to 20 minutes) of PMN with staurosponne resulted in a twofold enhancement of the fMLP-induced RB and in partial restoration of phosphorylation of the p47 phox (Figs 1 and 8) . However, the maximal restoration of phosphorylation reached only about 50% of control values (Fig 8) , whereas the primed RB was enhanced by approximately 200%, indicating a dissociation between RB and enhanced phosphorylation of p47 phox. Such a dissociation has also been described in unprimed PMN stimulated with retinalt5 and DiC8,I4 as well with fMLP and concanavalin A.37 However, a link between the two responses is suggested by the fact that PKC inhibitors (sphingosine and staurosporine) reduced primed RB and partially inhibited the restoration of phosphorylation (Fig 8) , suggesting that recovery of p47 phox phosphorylation may contribute to the primed RB.
Potential mechanisms for the recovery of the phosphorylation of p47 phox theorically include processes that may ( I ) reverse the PKC inhibition set up during short treatment with staurosponne, (2) inhibit phosphatase activation, or (3) involve kinases weakly sensitive (or insensitive) to staurosporine. In preliminary experiments with a phosphatase inhibitor, okadaic acid, which also primes fh4LP-induced RB?' restoration of phosphorylation in staurosporinetreated PMN persisted (results not shown). Although the results need to be confirmed with other phosphatase inhibitors, they suggest that the inhibition of serine and threonine phosphatase activation may not play be important in the staurosporine-priming effect. The observation that long treatment of PMN with staurosporine failed to enhance the PMA-induced RB and phosphorylation of the p47 (Fig 5) indicates that staurosporine does not induce metabolic processes that reverse PKC inhibition in this model. However, in fMLP-stimulated PMN, such a process may exist, because staurosporine and sphingosine were able to partially inhibit staurosporine-mediated priming of the RB and the restoration of p47 phox phosphorylation. The residual RB that was not inhibited by staurosporine or sphingosine may be due to kinase-independent processes or to kinases weakly sensitive (or insensitive) to these inhibitors.
The involvement of PKC-independent mechanisms in RB has been suggested with intact PMN treated with retinaIt5 and DiC8,I4 cell-free systems derived from PMN,"9-52 and reconstituted Such cell-free systems have shown several apparent discrepancies between the superoxide production by intact cells and PMN membranes. They are usually composed of membranes, cytosolic protein factors, magnesium, and an anionic lipid, eg, SDS" or fatty acids such as arachidonic acid56 and ph~sphatidate.~~ It has been suggested that the presence of an anionic lipid can mimick phosphorylation of p47 phox for its role in superoxide production. 16 We recently reported that in human PMN treated by staurosporine, phosphatidic acid (PA) levels increased in a time-and concentration-dependent manner, peaking at 15 to 20 minutes.57 Enhanced PA levels appear to be due to both phospholipase-D activation and inhibition of PA dephosphorylation and also reach a level close to that induced by fMLP in PMN not treated with cytochalasin B (results not shown). In other studies, staurosporine potentiated NLP-induced PA productions8 and arachidonic release." PA production has been correlated with RB.6096L These observations raise the possibility that long treatment (1 5 minutes) with staurosporine followed by stimulation with fMLP results in a sufficient amount of mediators (PA and arachidonic acid) to achieve an exaggerated RB through a mechanism that does not involve phosphorylation. Alternatively, the mediators could reverse the inhibition of a PKC-dependent pathway, as suggested by the restoration of p47 phox phosphorylation.
In addition to enhancing PMN RB stimulation, staurosporine stimulates actin polymerization,62 degranulation," and calcium m~b i l i z a t i o n .~~
In human basophils, staurosporine and sphingosine prime fMLP-induced degranulat i~n .~~ In other cell types, staurosporine promotes changes in morphology and differentiation2' and mimics nerve growth factor for the induction of neuropeptide gene exp r e~s i o n .~~ In an in vitro system, staurosporine promotes the association of PKC to vesicles. 66 We have shown that staurosporine enhances the expression of phorbol dibutyrate binding sites in PMN, probably due to translocation of PKC.67 Whereas the molecular mechanism of these stimulating effects of staurosporine remains to be clarified, these data indicate that staurosporine has numerous stimulating effects that may not be related to kinase alterations.
In conclusion, the stimulation of PMN RB by fMLP was both inhibited and primed when PMN were treated for short and long periods with staurosporine, respectively. This is in contrast with the PMA-mediated RB, which was always depressed. Inhibited and potentiated RB were associated with decreased and partial restoration of p47 phox phosphorylation, respectively, suggesting a possible role of phosphorylation recovery in primed RB. These results suggest that staurosporine may alter the interactions between different kinases, resulting in time-dependent changes in signalling pathways and primed functions. This study also emphasizes the care that must be taken in interpreting alterations of cellular responses by kinase inhibitors. For personal use only. on September 24, 2017. by guest www.bloodjournal.org From
